CD133 mainly gained interest after experiments showing that a CD133+ subpopulation in a brain tumor had stem cell properties in vivo. After transplantation of only about 100 CD133+ cells into immune deficient mice, the exact same tumor was induced, whereas this was not the case for the same number of CD133− cells [35,36]. Here, PROM1 is linked to neoplasm.